619-99-8Relevant articles and documents
Silica-immobilized ionic liquid Br?nsted acids as highly effective heterogeneous catalysts for the isomerization of: N -heptane and n -octane
Al-Fatesh, Ahmed S.,Dhar, Abhishek,Fakeeha, Anis H.,Ibrahim, Ahmed A.,Khimani, Mehul,Patel, Hiren,Siva Kumar, Nadavala,Vekariya, Rohit L.
, p. 15282 - 15292 (2020/05/05)
Metal-free imidazolium-based ionic liquid (IL) Br?nsted acids 1-methyl imidazolium hydrogen sulphate [HMIM]HSO4 and 1-methyl benzimidazolium hydrogen sulphate [HMBIM]HSO4 were synthesized. Their physicochemical properties were investigated using spectroscopic and thermal techniques, including UV-Vis, FT-IR, 1H NMR, 13C-NMR, mass spectrometry, and TGA. The ILs were immobilized on mesoporous silica gel and characterized by FT-IR spectroscopy, scanning electron microscopy, Brunauer-Emmett-Teller analysis, ammonia temperature-programmed desorption, and thermogravimetric analysis. [HMIM]HSO4?silica and [HMBIM]HSO4?silica have been successfully applied as promising replacements for conventional catalysts for alkane isomerization reactions at room temperature. Isomerization of n-heptane and n-octane was achieved with both catalysts. In addition to promoting the isomerization of n-heptane and n-octane (a quintessential reaction for petroleum refineries), these immobilized catalysts are non-hazardous and save energy.
Compositions and methods for the treatment of multiple sclerosis
-
, (2015/09/22)
The present invention relates to compounds of Formula I and Formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of Formula I and Formula II; and formulated to treat an underlying etiology by oral administration, delayed release or sustained release, transmucosal, syrup, topical, parenteral administration, injection, subdermal, oral solution, rectal administration, buccal administration or transdermal administration.
Hydroisomerization of n-octane on molybdenum based catalyst
Al-Kandari,Al-Kharafi,Katrib
scheme or table, p. 141 - 148 (2010/11/03)
Balanced metal-acid bifunctional MoO2-x(OH)y catalytic system has been prepared. 2-3 monolayers of this phase on the sample surface were obtained following controlled reduction by hydrogen of equivalent 5 monolayers of MoO3/sub